C-type natriuretic peptide - Chugai Pharmaceuticals/University of Kyoto

Drug Profile

C-type natriuretic peptide - Chugai Pharmaceuticals/University of Kyoto

Alternative Names: CNP analogue- Chugai Pharmaceuticals/University of Kyoto

Latest Information Update: 27 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chugai Pharmaceutical; Kyoto University
  • Class Cyclic peptides; Natriuretic agents; Natriuretic peptides; Recombinant proteins
  • Mechanism of Action C-type natriuretic peptide stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Achondroplasia

Most Recent Events

  • 03 Mar 2016 Discontinued - Preclinical for Achondroplasia in Japan before March 2016 (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top